LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the pricing of an underwritten public offering of 3,600,000 shares of its common stock at a price to the public of $48.25 per share. The number of shares reflects an increase of 600,000 shares over the number of shares anticipated to be sold as previously announced. AMAG Pharmaceuticals also granted the underwriters an over-allotment option for an additional 540,000 shares. All of the shares are being offered by AMAG Pharmaceuticals. The offering is expected to close on or about January 26, 2010, subject to customary closing conditions.
